Results 201 to 210 of about 13,213,530 (364)

Broadening the Capture of Natural Products Mentioned in FAERS Using a Combined Approach

, 2023
Israel O. Dilan-Pantojas, Tanupat Boonchalermvichien, Sanya B. Taneja, Xiaotong Li, Maryann R. Chapin, Sandra Karcher, Richard D. Boyce   +6 more
openalex   +2 more sources

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Biological Roles of Melanin and Natural Product-Derived Approaches for Its Modulation. [PDF]

Int J Mol Sci
Hong S, Lim H, Kim DH.
europepmc   +1 more source

The hidden enzymology of bacterial natural product biosynthesis

Nature Reviews Chemistry, 2019
T. Scott, J. Piel
semanticscholar   +1 more source

Recent developments in the isolation, biological function, biosynthesis, and synthesis of phenazine natural products

, 2017
Nikolaus Guttenberger, Wulf Blankenfeldt, Rolf Breinbauer   +2 more
openalex   +2 more sources

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis Care &Research, EarlyView.
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla, Robert Lafyatis, Kevin F. Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J. Kass   +13 more
wiley   +1 more source

Dihydrotanshinone as a Natural Product-Based CYP17A1 Lyase Inhibitor for Hyperandrogenic Disorders. [PDF]

Biomolecules
Li K, Yakubu J, Jørgensen FS, Pandey AV.   +3 more
europepmc   +1 more source

Natural-Product-Derived Carbon Dots: From Natural Products to Functional Materials.

ChemSusChem, 2018
Xinyue Zhang, Mingyue Jiang, N. Niu, Zhijun Chen, Shujun Li, Shouxin Liu, Jian Li   +6 more
semanticscholar   +1 more source

Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point

, 2017
Tiago Rodrigues
openalex   +2 more sources

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

Arthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source